TXNIP and metabolic dysfunction-associated steatotic liver disease: In the liver, TXNIP is significantly upregulated in metabolic dysfunction-associated steatotic liver disease (MASLD) patients and mediates lipogenesis and fatty acid re-esterification 11, 12.